IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Contravir Pharmaceuticals in

CUSIP: 21234W103 | 79 institutional holders

Quarters

Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

Vantage Investment Advisors, LLC143
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vantage Investment Advisors, LLC
143$00.0%N/AN/AState College, PA2018-08-13